Shanghai Shen Lian Biomedical Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 358.43 million compared to CNY 337.73 million a year ago. Net income was CNY 110.2 million compared to CNY 129.51 million a year ago. Basic earnings per share from continuing operations was CNY 0.27 compared to CNY 0.32 a year ago. Diluted earnings per share from continuing operations was CNY 0.27 compared to CNY 0.31 a year ago.